Investment Type: Venture Capital
Investment Stage: Series B
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 26.04.2023 | Evommune | evommune.c... | $140.5M | United Sta... |
| 18.11.2022 | Lucy Thera... | lucytherap... | - | United Sta... |
| 05.11.2022 | ARKUDA The... | arkudatx.c... | $108M | United Sta... |
| 05.11.2022 | HotSpot Th... | hotspotthe... | $210M | United Sta... |
| - | SutroVax | sutrovax.c... | $281M | United Sta... |
| - | Vigil Neur... | vigilneuro... | $215M | United Sta... |
| - | Fusion Pha... | fusionphar... | $195.91M | Canada, On... |
| - | Plexium | plexium.co... | $165M | United Sta... |
| - | Oculis S.A... | oculis.com | $133.47M | Switzerlan... |
| - | Akouos | akouos.com | $162.5M | United Sta... |
Show more
Mentions in press and media 8
| Date | Title | Description | Source |
| 07.05.2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with ... | startuptic... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, wit... | startuptic... |
| 05.01.2018 | Oculis raises CHF20 million and moves to Switzerland | The financing was led by a syndicate of leading international life science investors including Nov... | startuptic... |
| 04.01.2018 | Oculis Raises $20.3M Series B from Novartis Venture Fund | Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakt... | citybizlis... |
| 21.05.2017 | Domain Associates Joins $65M Series B for Iterum | Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the developme... | citybizlis... |
| 21.05.2017 | Iterum Raises $65M Series B | Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the developme... | citybizlis... |
| 16.03.2017 | Pivotal bioVenture Partners Closes $300M First Life Sciences... | San Francisco, CA-based venture capital firm Pivotal bioVenture Partners closed its first fund, at o... | finsmes.co... |
| - | Fusion Pharmaceuticals Raises $105 Million In Oversubscribed... | Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-parti... | healthcap.... |